Emerging Therapeutics & Technologies Stream

- 新興療法 -

Cutting-Edge Science and Technology to Deliver New Therapeutic Applications

The Emerging Therapeutics & Technologies stream presents three emerging and fast-developing topics, that represent the latest trends and future outlook for many biologics developers. Emerging Indications for Therapeutic Antibodies will reveal new targets and novel mechanisms of actions for development of next-generation therapeutics beyond oncology. Gene Therapy: Advancing from Bench to Clinic will explore the exciting landscape of gene therapy, from cutting-edge technologies to delivery challenges and vector analytics, to preclinical and clinical updates. The week closes with a CRISPR for Genome Editing training seminar that will introduce the basic principles of genetic engineering and provide insights into using CRISPR to treat genetic diseases.

Conferences Include:

5月4 - 5日

Emerging Indications for Therapeutic Antibodies
( 治療用抗體的新適應症 )

5月6 -7日

Gene Therapy
( 基因療法 )

5月7 - 8日

Genome Editing with CRISPR
( 透過CRISPR的基因組剪輯 )

Keynote Speakers:


Madhusudan Natarajan, PhD Head, Rare Diseases DDU, Takeda

Mike Singer, PhD Medical Officer, Division of Clinical Evaluation and Pharmacology/Toxicology, Center for Biologics Evaluation and Research, FDA

Choose your language